bionlp-st-ge-2016-spacy-parsed Home  

PMC:1310901 / 1014-1235 JSONTXT 14 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T576 0-5 RB denotes First
T577 5-6 , denotes ,
T578 7-16 NN denotes treatment
T579 17-19 IN denotes of
T580 20-34 JJ denotes IRF-4-negative
T581 35-43 NN denotes lymphoid
T582 43-44 , denotes ,
T583 45-52 JJ denotes myeloid
T584 53-56 CC denotes and
T585 57-66 JJ denotes monocytic
T586 67-71 NN denotes cell
T587 72-77 NNS denotes lines
T588 78-82 IN denotes with
T589 83-86 DT denotes the
T590 87-108 NN denotes methylation-inhibitor
T591 109-130 JJ denotes 5-aza-2-deoxycytidine
T592 131-139 VBD denotes resulted
T593 140-142 IN denotes in
T594 143-144 DT denotes a
T595 145-149 NN denotes time
T596 149-150 : denotes -
T597 151-154 CC denotes and
T598 155-178 JJ denotes concentration-dependent
T599 179-187 NN denotes increase
T600 188-190 IN denotes of
T601 191-196 NNP denotes IRF-4
T602 197-201 NNP denotes mRNA
T603 202-205 CC denotes and
T604 206-213 NN denotes protein
T605 214-220 NNS denotes levels
T606 220-221 . denotes .
R465 T576 T592 advmod First,resulted
R466 T577 T592 punct ",",resulted
R467 T578 T592 nsubj treatment,resulted
R468 T579 T578 prep of,treatment
R469 T580 T581 amod IRF-4-negative,lymphoid
R470 T581 T579 pobj lymphoid,of
R471 T582 T581 punct ",",lymphoid
R472 T583 T581 conj myeloid,lymphoid
R473 T584 T583 cc and,myeloid
R474 T585 T583 conj monocytic,myeloid
R475 T586 T587 compound cell,lines
R476 T587 T578 pobj lines,treatment
R477 T588 T587 prep with,lines
R478 T589 T591 det the,5-aza-2-deoxycytidine
R479 T590 T591 compound methylation-inhibitor,5-aza-2-deoxycytidine
R480 T591 T588 pobj 5-aza-2-deoxycytidine,with
R481 T592 T592 ROOT resulted,resulted
R482 T593 T592 prep in,resulted
R483 T594 T595 det a,time
R484 T595 T593 pobj time,in
R485 T596 T592 punct -,resulted
R486 T597 T592 cc and,resulted
R487 T598 T599 amod concentration-dependent,increase
R488 T599 T605 nmod increase,levels
R489 T600 T599 prep of,increase
R490 T601 T602 compound IRF-4,mRNA
R491 T602 T600 pobj mRNA,of
R492 T603 T599 cc and,increase
R493 T604 T605 compound protein,levels
R494 T605 T592 conj levels,resulted
R495 T606 T592 punct .,resulted